Our mission is to continuously improve the treatment of children with congenital heart disease and other heart conditions and to advance the complex science that underlies these treatments. To help meet this goal, the Benderson Family Heart Center maintains an active roster of clinical trials and ongoing research.
For more than 50 years, Boston Children’s has pioneered cardiovascular innovations that have dramatically improved survival rates and the quality of life for children born with heart defects. The Benderson Family Heart Center attracts major research support from funding agencies, including the National Institutes of Health and the American Heart Association. We have the nation’s largest clinical and basic research program focused on pediatric heart disease, and we are an innovator in translational research, bringing laboratory discoveries to the bedside as quickly as possible.
Innovation plays a critical role in our patients’ health, so we are constantly creating new ways to treat heart diseases. Our scientists investigate every aspect of the heart and the conditions that affect it, so we can offer new and improved treatments to our patients. Our program's culture is one of innovation — of solving difficult problems that others haven't been able to solve, tackling the most complex cases, and figuring out ways to make the process easier on patients.